Carnitine-associated encephalopathy caused by long-term treatment with an antibiotic containing pivalic acid

Pediatrics

Volumn 120, Issue 3, 2007, Pages

  Makino, Yasuko ^a   Sugiura, Tokio ^a   Ito, Tetsuya ^b   Sugiyama, Naruji ^c   Koyama, Norihisa ^a  

^a TOYOHASHI MUNICIPAL HOSPITAL   (Japan)

^b NAGOYA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCES   (Japan)

^c AICHI GAKUIN UNIVERSITY   (Japan)

Author keywords

Antibiotics; Carnitine; Encephalopathy; Hypoglycemia; Otitis media; Pivalic acid

Indexed keywords

ACICLOVIR; ANTIBIOTIC AGENT; CARNITINE; CEFDITOREN PIVOXIL; DEXAMETHASONE; DIAZEPAM; GLUCOSE; IMMUNOGLOBULIN; KETONE DERIVATIVE; LACTIC ACID;

ABSENCE OF SIDE EFFECTS; ARTICLE; CARNITINE DEFICIENCY; CASE REPORT; CLINICAL FEATURE; CONSCIOUSNESS DISORDER; CONVALESCENCE; DIAGNOSTIC PROCEDURE; DISEASE COURSE; DISEASE EXACERBATION; DISEASE SEVERITY; ENCEPHALITIS; GLASGOW COMA SCALE; GRAND MAL SEIZURE; HUMAN; HYPOGLYCEMIA; LABORATORY TEST; LONG TERM CARE; MALE; METABOLIC ACIDOSIS; NEWBORN INTENSIVE CARE; OTITIS MEDIA; PRESCHOOL CHILD; PRESCRIPTION; PRIORITY JOURNAL; RECURRENT DISEASE; TREATMENT FAILURE; TREATMENT OUTCOME;

ACIDOSIS; ANTI-BACTERIAL AGENTS; BRAIN DISEASES, METABOLIC; CARNITINE; CEPHALOSPORINS; HUMANS; HYPOGLYCEMIA; INFANT; INFUSIONS, INTRAVENOUS; MALE; OTITIS MEDIA; PENTANOIC ACIDS; SEIZURES; UNCONSCIOUSNESS; VITAMIN B COMPLEX;

EID: 34548434010     PISSN: 00314005     EISSN: 02105721     Source Type: Journal    
DOI: 10.1542/peds.2007-0339     Document Type: Article

References (15)

1. Osorio JH, Pourfarzam M. Plasma free and total carnitine measured in children by tandem mass spectrometry. Braz J Med Biol Res. 2002;35:1265-1271
2. Bremer J. Carnitine: metabolism and functions. Physiol Rev. 1983;63:1420-1480
3. Carnitine deficiency. Lancet. 1990;335:631-633
4. Stanley CA. Carnitine deficiency disorders in children. Ann N Y Acad Sci. 2004;1033:42-51
5. Abrahamsson K, Eriksson BO, Holme E, Jodal U, Lindstedt S, Nordin I. Impaired ketogenesis in carnitine depletion caused by short-term administration of pivalic acid prodrug. Biochem Med Metab Biol. 1994;52:18-21
6. Melegh B, Kerner J, Bieber LL. Pivampicillin-promoted excretion of pivaloylcarnitine in humans. Biochem Pharmacol. 1987;36:3405-3409
7. Holme E, Greter J, Jacobson C, et al. Carnitine deficiency induced by pivampicillin and pivmecillinam therapy. Lancet. 1989;2(8661):469-473
8. Holme E, Jodal U, Linstedt S, Nordin I. Effects of pivalic acid-containing prodrugs on carnitine homeostasis and on response to fasting in children. Scand J Clin Lab Invest. 1992;52:361-372
9. Ito T, Sugiyama N, Kobayashi M, et al. Alteration of ammonia and carnitine levels in short-term treatment with pivalic acid-containing prodrug. Tohoku J Exp Med. 1995;175:43-53
10. Abrahamsson K, Holme E, Jodal U, Lindstedt S, Nordin I. Effect of short-term treatment with pivalic acid containing antibiotics on serum carnitine concentration: a risk irrespective of age. Biochem Mol Med. 1995;55:77-79
11. Brass EP, Mayer MD, Mulford DJ, Stickler TK, Hoppel CL. Impact on carnitine homeostasis of short-term treatment with the pivalate prodrug cefditoren pivoxil. Clin Pharmacol Ther. 2003;73:338-347
12. Teraoka M, Wada T, Ogura K, et al. A patient with hypocarnitinemia after long-term treatment of antibiotics [in Japanese]. J Jpn Pediatr Soc. 2004;108:1059-1061
13. William LN, Bruce AB, Pinar TO. Atlas of Metabolic Diseases. 2nd ed. New York, NY: Hodder Arnold Publication; 2005:260-266
14. Hino K, Nishikawa M, Sato E, Inoue M. L-carnitine inhibits hypoglycemia-induced brain damage in the rat. Brain Res. 2005;1053:77-87
15. Bieber LL. Carnitine. Annu Rev Biochem. 1988;57:261-283